期刊
ANTIBIOTICS-BASEL
卷 12, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/antibiotics12010025
关键词
aminoglycoside modifying enzymes; ribosomal methyltransferases; antibacterials; antiribosomal activity; aminoglycoside antibiotics
The synthesis, antiribosomal, and antibacterial activity of two anomers of a novel apralog, 5-O-(5-amino-3-C-dimethylaminopropyl-D-ribofuranosyl)apramycin, were studied. Both anomers showed strong activity against bacterial ribosomes, MRSA, and various wild-type Gram-negative pathogens. These compounds were also found to be effective against aminoglycoside modifying enzymes, enabling them to retain their activity in the presence of these enzymes. Surprisingly, the two anomers exhibited comparable activity against bacterial ribosomes and the tested bacterial strains.
The synthesis and antiribosomal and antibacterial activity of both anomers of a novel apralog, 5-O-(5-amino-3-C-dimethylaminopropyl-D-ribofuranosyl)apramycin, are reported. Both anomers show excellent activity for the inhibition of bacterial ribosomes and that of MRSA and various wild-type Gram negative pathogens. The new compounds retain activity in the presence of the aminoglycoside phosphoryltransferase aminoglycoside modifying enzymes that act on the primary hydroxy group of typical 4,5-(2-deoxystreptamine)-type aminoglycoside and related apramycin derivatives. Unexpectedly, the two anomers have comparable activity both for the inhibition of bacterial ribosomes and of the various bacterial strains tested.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据